Related Experiment Video
Updated: Jun 3, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Myeloproliferative disorders in pregnancy
Claire N Harrison1, Susan E Robinson
1Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, UK. Claire.Harrison@gstt.nhs.uk
Hematology/Oncology Clinics of North America
|March 30, 2011
Summary
This review examines pregnancy outcomes for women with myeloproliferative neoplasms (MPN), identifying risk factors and management strategies for improved maternal and infant health.
Area of Science:
- Hematology
- Obstetrics
- Reproductive Medicine
Background:
- Myeloproliferative neoplasms (MPN) are a group of diseases that affect blood cell production.
- Pregnancy in women with MPN presents unique challenges and potential risks.
- Understanding pregnancy outcomes and risk factors is crucial for effective management.
Purpose of the Study:
- To review pregnancy outcomes in women diagnosed with MPN.
- To discuss potential risk markers and the pathogenesis of adverse pregnancy outcomes.
- To outline diagnostic and management strategies for MPN in women of reproductive age.
Main Methods:
- Literature review of studies on MPN and pregnancy.
- Analysis of risk factors associated with poor pregnancy outcomes in MPN patients.
- Description of a management strategy for pregnant MPN patients.
Main Results:
- Pregnancy outcomes in women with MPN can vary, with certain factors increasing risk.
- Identification of key diagnostic and management considerations for MPN in women of reproductive potential.
- A structured approach to managing standard and high-risk pregnancies in MPN patients.
Conclusions:
- Effective management strategies are essential for improving pregnancy outcomes in women with MPN.
- Further research into risk markers and pathogenesis can enhance patient care.
- Multidisciplinary care is vital for optimizing outcomes in pregnant MPN patients.
Related Concept Videos
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...